NovoCure
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.About NVCR
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
NVCR Key Statistics
Stock Snapshot
As of today, NovoCure(NVCR) shares are valued at $13.70. The company's market cap stands at 1.53B, with a P/E ratio of -8.48.
On 2025-12-12, NovoCure(NVCR) stock moved within a range of $13.22 to $13.94. With shares now at $13.70, the stock is trading +3.6% above its intraday low and -1.7% below the session's peak.
Trading volume for NovoCure(NVCR) stock has reached 1.98M, versus its average volume of 2.01M.
Over the past 52 weeks, NovoCure(NVCR) stock has traded between a high of $34.13 and a low of $10.70.
Over the past 52 weeks, NovoCure(NVCR) stock has traded between a high of $34.13 and a low of $10.70.
NVCR News
NovoCure has announced that CEO and Director Ashley Cordova resigned effective November 30, 2025, with President Frank Leonard stepping into the Chief Executive...
